The substance use disorder (SUD) industry has dramatically changed in recent years, adjusting to new technology, regulations and medications. The SUD platform of the future will take into account trends with payers and technology, industry insiders told Addiction Treatment Business, and continually re-educate itself on the best treatment modalities. Still, future-proofing SUD providers must keep […]

Virtual mental health provider Talkspace (Nasdaq: TALK) has inked a deal with digital addiction operator Bicycle Health to provide both companies’ patients with access to both therapy and opioid use disorder (OUD) treatment. More than 21 million adults have both a mental illness and substance use disorder (SUD), according to the 2022 National Survey on […]

In recent years, substance use disorder (SUD) treatment programs have become shorter and outpatient treatment program options have become more popular. Residential inpatient treatment programs, often more expensive than outpatient options, may be going out of vogue among payers and investors. Still, patients will always need an option for residential care, industry insiders told Addiction […]

A class of synthetic opioids that are 10 times as potent as fentanyl is becoming increasingly prevalent in the United States. The substance use disorder (SUD) industry may not be sufficiently prepared for its impacts. Nitazenes, a class of synthetic opioids first developed in the 1950s as opioid analgesics and never approved to market, are […]

Behavioral health operator Turnbridge is in talks to sell, touting about $15 million of EBITDA. Turnbridge, which provides mental health and substance use disorder (SUD) care, is pursuing a sale of the company, according to Axios. Investment banking firm Raymond James was hired to lead the sale, sources say.  New Haven, Connecticut-based Turnbridge offers gender-specific […]

Medications for opioid use disorder (MOUDs), including buprenorphine, save lives among people with opioid use disorder (OUD). Long-lasting injectable versions offer the same benefits and can help patients adhere to medication schedules.  Despite injectable buprenorphine’s benefits, a new study published in JAMA found that the class of drugs is only available at one-third of substance […]

Drug-related overdose deaths among teens more than doubled between 2019 and 2020, despite adolescent drug use becoming less common. Teen overdoses have reached a crisis point, a new study published in the New England Journal of Medicine found, with an average of 22 adolescents dying from drug overdoses every week in 2022. Fentanyl is among […]

The outpatient substance use disorder (SUD) industry has evolved from a landscape of mom-and-pop businesses to a field dominated by sophisticated providers seeking to provide quality care. While the SUD industry has matured over the last decade, it still faces significant roadblocks like stigma surrounding medication-assisted treatment (MAT) and fragmentation. The splintered SUD market offers […]

GEHA Ventures made its first investment in You Are Accountable to enable better access to substance use disorder treatment care. New York City-based You Are Accountable raised $2 million late last year in a funding round led by GEHA Ventures. The recently formed venture capital investment entity invested in the startup because Accountable’s focus is […]

Clinicians may not be fully aware of poppy seed tea, a novel opioid made using easily obtained unwashed poppy seeds. Poppy seed tea has similar risks to other opioids, including the potential for death, according to research led by Scott Weiner, Bicycle Health’s director of research and emergency physician. Patients who seek treatment for poppy […]